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Development  and  Psychometric  Evaluation  of  the  Lung  Cancer  Screening  Health  Belief  Scales  
  
Lung  cancer  is  the  deadliest  cancer  worldwide  regardless  of  gender  or  ethnicity.  Most  
lung  cancer  patients  are  diagnosed  with  advanced  disease;;  individuals  with  Stage  IV  lung  
cancer  have  a  five-­year  relative  survival  rate  of  1%.1  Tobacco  smoking  has  been  linked  to  90%  
of  all  lung  cancer  cases  and  is  the  number  one  risk  factor.1  Long-­term  smokers,  defined  as  age  
55  or  older  who  have  a  minimum  of  a  30  pack-­year  tobacco  smoking  history  and  currently  
smoke,  or  former  smokers  who  quit  within  the  past  15  years,  are  at  greatest  risk  for  the  
development  of  lung  cancer.    
Lung  cancer  screening  with  low-­dose  computed  tomography  (LDCT)  in  long-­term  
smokers  has  been  shown  to  decrease  relative  lung  cancer-­related  mortality  by  20%.2  In  
response  to  empiric  findings  from  the  National  Lung  Screening  Trial  (N  =  53,456),  the  United  
States  Preventive  Services  Task  Force  (USPSTF)  issued  guidelines  recommending  annual  
LDCT  for  long-­term  smokers.3  The  USPSTF’s  Grade  B  recommendation  reflects  their  
conclusion  that  available  evidence  was  sufficient,  with  high  certainty,  that  annual  LDCT  will  yield  
moderate  to  substantial  benefits  for  this  high-­risk  group.  As  a  result,  in  the  United  States,  the  
Centers  for  Medicare  and  Medicaid  Services  (CMS)  approved  coverage  of  LDCT  for  its  high-­risk  
members  in  February  2015.4    
Lung  cancer  screening  participation  is  influenced  by  many  factors  at  multiple  levels,  
including  individual,  provider,  and  health  care  system.  It  is  essential  to  understand  these  factors  
in  order  to  advance  on  shared  decision-­making  between  health  care  providers  and  their  high-­
risk  patients  about  lung  cancer  screening.  Understanding  individual  health  beliefs  about  
screening  among  long-­term  smokers  is  a  critical  component  of  future  efforts  to  facilitate  patient-­
provider  conversations  about  lung  cancer  screening  participation,  which  is  a  requirement  for  




The  Expanded  Health  Belief  Model  (HBM)  is  a  commonly  used  framework  to  explain  
what  motivates  individuals  to  participate  in  health-­promoting  behaviors,  such  as  cancer  
screening.5-­7  The  Expanded  HBM  has  been  used  to  explain  other  types  of  cancer  screening  
behavior  such  as  for  breast  and  colorectal  cancers,6,7  and  is  applicable  in  the  context  of  lung  
cancer.  Major  constructs  incorporated  from  the  model  and  reflected  in  the  development  of  these  
scales  include  perceived  risk  for  lung  cancer  as  well  as  perceived  benefits  of,  perceived  barriers  
to,  and  self-­efficacy  for  lung  cancer  screening.  Although  the  Expanded  HBM  delineates  
separate  constructs  for  perceived  risk  and  perceived  severity,  numerous  studies  have  reported  
that  perceived  severity  is  not  useful  in  explaining  cancer  screening  behavior  because  cancer  is  
universally  perceived  to  be  severe.8-­10  Therefore,  we  did  not  develop  a  measure  for  this  HBM  
construct.  
Perceived  risk  is  conceptually  defined  as  an  individual’s  belief  in  the  likelihood  that  he  or  
she  will  develop  lung  cancer  11-­13  and  has  been  shown  to  predict  intention  to  screen  for  lung  
cancer.11  Perceived  benefits  are  defined  as  the  belief  in  the  efficacy  of  an  advised  course  of  
action  to  reduce  risk.14  In  relation  to  lung  cancer  screening,  perceived  benefits  are  the  
individual’s  beliefs  about  the  positive  outcomes  associated  with  lung  cancer  screening.  
Perceived  barriers  are  defined  as  an  individual’s  belief  about  the  costs  (i.e.,  tangible  and  
psychological)  of  the  advised  course  of  action.14  In  the  context  of  lung  cancer,  perceived  
barriers  are  a  person’s  estimation  of  the  level  of  challenge  associated  with  lung  cancer  
screening  participation.11-­13  Finally,  self-­efficacy  is  defined  as  the  confidence  individuals  have  in  
their  ability  to  take  action  14  such  as  the  confidence  one  has  in  their  ability  to  perform  all  tasks  
related  to  arranging  and  completing  lung  cancer  screening.  The  figure  depicts  our  conceptual  
model  linking  key  psychological  variables  and  the  Expanded  HBM  constructs  to  explain  factors  





The  purpose  of  this  paper  is  to  describe  the  development  and  psychometric  testing  of  
four  new  scales  to  measure  the  following  lung  cancer  screening  health  beliefs:  (1)  perceived  risk  
of  lung  cancer;;  (2)  perceived  benefits  of  lung  cancer  screening;;  (3)  perceived  barriers  to  lung  
cancer  screening;;  and  (4)  self-­efficacy  for  lung  cancer  screening.  To  our  knowledge,  there  are  
no  scales  to  measure  HBM  constructs  in  the  context  of  lung  cancer  screening.  Using  the  
framework  originally  established  by  Champion  for  breast  cancer  screening  15  and  extended  by  
Rawl  for  colorectal  cancer  screening,16  the  authors  developed  the  lung  cancer  screening  health  
belief  scales.  Measurement  of  individual  health  beliefs  in  the  context  of  lung  cancer  screening  
will  enable  investigators  to  determine  the  relationships  between  the  theoretical  constructs  of  an  
established  model  and  lung  cancer  screening  participation  in  high-­risk  smokers.  Establishing  
valid  and  reliable  measures  of  health  beliefs  specific  to  lung  cancer  screening  will  provide  
greater  understanding  of  the  influence  of  perceptions  of  risk,  benefits,  barriers,  and  self-­efficacy  
which,  if  found  to  predict  lung  cancer  screening  behavior,  would  be  potential  targets  that  could  
be  modified  in  interventions.  Many  studies  in  other  types  of  cancer  screening  demonstrate  the  
ability  of  theory-­based  interventions  to  successfully  increase  screening  rates.5,6,17    
To  examine  the  psychometric  properties  of  the  scales,  we  tested  the  following  
hypotheses:  (1)  each  scale  will  demonstrate  adequate  content  validity  as  evidenced  by  a  total  
scale  content  validity  index  of  at  least  .80  when  evaluated  by  an  expert  panel;;  (2)  each  scale  will  
demonstrate  adequate  internal  consistency  reliability  with  Cronbach’s  alphas  of  .70  or  higher;;  
(3)  significant  differences  will  be  observed  in  mean  scores  on  the  scales  between  individuals  
who  intend  to  be  or  have  been  screened  for  lung  cancer  and  those  who  have  not;;  and  (4)  a  4-­
factor  (perceived  risk  of  lung  cancer,  perceived  benefits  of,  perceived  barriers  to,  and  self-­
efficacy  for  lung  cancer  screening)  confirmatory  factor  analysis  model  will  be  consistent  with  
observed  data  and  individual  lung  cancer  screening  health  belief  items  will  demonstrate    




Phase  I:  Development  and  Content  Validation  
The  four  scales  tested  in  this  study  were  developed  using  the  following  methods:  (1)  
extensive  review  of  the  literature  on  lung  cancer  screening  specifically  as  well  as  other  types  of  
cancer  screening  in  general;;  (2)  appropriate  and  applicable  modification  of  items  from  
Champion’s  breast  cancer  screening  health  belief  scales15  and  Rawl’s  colorectal  cancer  
screening  health  belief  scales;;16  (3)  focus  groups  conducted  to  generate  qualitative  data  on  
health  beliefs  related  to  lung  cancer  screening;;  and  (4)  evaluation  and  feedback  from  a  panel  of  
10  content  experts.  Individual  items  for  the  lung  cancer  screening  health  belief  scales  were  
initially  developed  by  modifying  the  health  belief  scales  in  breast  and  colorectal  cancer  
screening  and  by  an  extensive  review  of  the  literature  on  the  four  constructs  specific  to  lung  and  
other  types  of  cancer  screening.  Focus  group  discussions  were  then  conducted  with  four  
groups:  two  groups  of  long-­term  current  and  former  smokers  who  had  recently  been  screened  
for  lung  cancer  with  LDCT;;  and  two  groups  of  screening  eligible  individuals  who  had  never  been  
screened.  Scale  items  were  revised  based  on  feedback  received  from  the  focus  groups.  
Content  Validity.  
An  expert  panel  examined  content  validity.  The  content  experts  evaluated  each  item  on  
the  four  scales  for  relevance,  clarity,  comprehensiveness,  and  appropriateness.  Relevance,  the  
degree  to  which  the  item  was  believed  to  be  relevant  to  the  concept  (i.e.,  perceived  risk,  
perceived  benefits,  perceived  barriers,  and  self-­efficacy)  was  rated  using  a  4-­point  response  
scale:  (1)  item  is  not  relevant;;  (2)  item  needs  major  revision  to  be  relevant;;  (3)  item  needs  minor  
revision  to  be  relevant;;  and  (4)  item  is  relevant.  Total  content  validity  indices  (CVI)  were  
calculated  for  each  scale.  Total  CVIs  is  a  mathematical  calculation  for  quantitatively  measuring  
the  content  validity  of  an  instrument.18  The  CVI,  or  proportion  agreement  method,  is  calculated  
using  the  ratings  of  item  relevance  by  a  panel  of  content  experts  indicating  level  of  agreement  
for  relevance  of  scale  items.  A  minimum  of  five  content  experts  is  recommended  to  provide  a  
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sufficient  level  of  control  for  chance  agreement.  As  defined  by  Lynn  using  the  4-­point  response  
scale,  a  total  scale  CVI  of  .78  or  higher  is  considered  acceptable  with  a  panel  of  10  content  
experts.19  Each  reviewer  was  given  a  packet  of  information  that  included:  (1)  purpose  of  the  
study;;  (2)  hypotheses;;  (3)  conceptual  and  operational  definitions;;  (4)  survey  instructions;;  and  (5)  
a  content  validity  survey  for  each  of  the  four  scales.  The  content  validity  survey  was  developed  
using  recommendations  outlined  by  Wynd,  Schmidt  and  Schaefer.20  Specific  instructions  for  
determining  the  relevance  of  each  of  the  items  comprising  the  four  scales  were  given  to  each  
content  expert,  who  then  completed  and  returned  them  to  the  researcher  electronically  or  by  
mail.  In  addition,  item  level  CVIs  were  calculated.  Items  that  were  unanimously  rated  as  not  
relevant  were  deleted.  Total  scale  level  CVIs  (reflective  of  relevance)  as  well  as  average  ratings  
for  clarity,  comprehensiveness,  and  appropriateness  are  presented  in  Table  1.  Two  members  of  
the  research  team  (XXX  and  XXX)  independently  reviewed  the  content  experts’  ratings  and  
suggestions  and  made  final  decisions  about  item  deletion,  modification,  retention,  and  addition  
through  discussion  to  reach  consensus.  
Phase  II:  Study  to  Test  Reliability  and  Construct  Validity  
Design.  
A  descriptive,  cross-­sectional  study  was  conducted  to  test  the  hypotheses  related  to  
internal  consistency  reliability  and  construct  validity  of  the  four  newly  developed  scales.  Internal  
consistency  reliability  was  tested  using  Cronbach’s  alpha.  Construct  validity  was  tested  by  two  
methods:  (1)  by  examining  scale  mean  differences  between  two  distinct  groups;;  and  (2)  through  
confirmatory  factor  analysis.  Because  lung  cancer  screening  is  a  new  recommendation  
(guidelines  issued  in  2013  and  Medicare  coverage  approved  in  2015),  the  pool  of  screened  
individuals  was  expected  to  be  small.  We  assessed  stage  of  adoption  for  lung  cancer  screening  
which  included  intention  to  screen  for  lung  cancer  in  the  next  six  months.  “Screeners”  are  
conceptually  defined  in  this  study  as  those  individuals  who  indicated  they  either  intended  to  
screen  for  lung  cancer  or  had  recently  completed  lung  cancer  screening.  Therefore,  construct  
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validity  was  first  tested  by  validating  proposed  theoretical  relationships  among  the  constructs  
based  on  the  performance  of  the  Health  Belief  Model  constructs  in  other  types  of  cancer  
screening.  Specifically,  if  the  perceived  risk  scale  was  measuring  the  construct  as  theoretically  
specified,  individuals  who  intended  to  and  had  screened  should  have  higher  levels  of  perceived  
risk  of  lung  cancer  than  those  who  had  not  screened.  Similarly,  individuals  classified  as  
screeners  should  have  higher  levels  of  perceived  benefits  and  self-­efficacy  for  lung  cancer  
screening  and  fewer  perceived  barriers  to  lung  cancer  screening  than  those  who  had  not  
screened.  
Secondly,  since  each  scale  was  developed  to  be  unidimensional,  construct  validity  also  
was  tested  through  confirmatory  factor  analysis.  This  analysis  model  was  chosen  to  
demonstrate  that  the  four  scales  are  independent  of  each  other  and  to  give  distinct  information  
on  each  construct  being  measured.  
Sample.  
Participants  were  recruited  using  a  variety  of  community-­based  recruitment  methods.    
Power  analysis  indicated  that  300  participants  were  needed  to  detect  a  .20  correlation  between  
scores  on  each  of  the  four  scales  and  lung  cancer  screening  participation.  Inclusion  criteria  
included:  (1)  age  55  to  77  years;;  (2)  30  pack-­year  tobacco  smoking  history;;  (3)  current  smoker  
or  former  smoker  who  had  quit  within  the  past  15  years;;  and  (4)  not  diagnosed  with  lung  cancer.  
Data  Collection.  
University  Institutional  Review  Board  approval  was  obtained.  Data  were  collected  via  a  
one-­time  web-­based  survey  using  the  REDCap  (Research  Electronic  Data  Capture)  system.  
REDCap  is  a  secure  web-­based  application  for  building  and  managing  online  surveys  and  
databases.  For  participants  who  agreed  to  participate  in  the  study  but  did  not  wish  to  complete  
the  survey  online,  a  paper  copy  of  the  survey  was  mailed  (n  =  16)  or  the  survey  was  





The  perceived  risk,  perceived  benefits,  perceived  barriers,  and  self-­efficacy  scales  are  
comprised  of  3,  6,  17,  and  9  items  respectively.  The  perceived  risk,  perceived  benefits,  and  
perceived  barriers  scales  use  4-­point  Likert-­style  responses  from  strongly  agree  to  strongly  
disagree.  The  self-­efficacy  scale  uses  4-­point  Likert-­style  responses  with  items  ranging  from  
very  confident  to  not  at  all  confident.  The  four  scales  were  included  in  a  larger  general  survey  
about  lung  health  that  collected  demographic  information,  including  participant  age,  marital  
status,  educational  level,  income,  gender,  smoking  status,  and  family  history  of  lung  cancer.  
Additional  items  assessing  social  influence,  media  exposure,  perceived  smoking-­related  stigma,  
health  care  provider  recommendation,  knowledge  about  lung  cancer  and  screening,  and  stage  
of  adoption  for  lung  cancer  screening  were  also  included.  
Data  Analyses.  
Data  were  entered  into  SAS  v9.4  (SAS  Institute,  Cary,  NC)  and  cleaned  by  examining  
frequencies  and  identifying  outliers.  Data  were  evaluated  for  normal  distributions  and  no  outliers  
were  noted.  Neither  the  four  scales,  nor  any  individual  item  of  the  four  scales,  had  more  than  
5%  missing  data.  Each  scale  was  summed  to  create  a  total  scale  score  for  the  analyses.  Data  
were  analyzed  using  Cronbach’s  alpha,  independent  samples  t  tests,  Pearson  chi-­square  tests,  
and  structural  equation  modeling  (SEM).  All  analyses  were  conducted  using  p  =  .05  as  the  
significance  level.  In  cases  where  parametric  assumptions  were  violated  (e.g.,  data  were  not  
normally  distributed),  non-­parametric  tests  were  used.  
Confirmatory  factor  analysis  was  performed  using  the  Mplus  software  package.  Scale  
items  were  specified  as  ordinal  categorical  variables  with  a  logit  link  to  their  factors  to  best  
theoretically  represent  the  Likert-­style  scale  format  of  the  surveys.  Goodness  of  fit  criteria  was  
used  to  determine  the  fit  of  the  data  to  the  model.  Data  were  analyzed  for  both  floor  and  ceiling  
effects  and  outliers.  Model  modification  indices  were  analyzed  to  determine  if  various  scale  




Phase  I:  Content  Validation  
Content  validity  was  evaluated  by  10  doctorally  prepared  behavioral  scientists  in  lung  
and  other  cancers  who  served  as  content  experts  and  represented  the  disciplines  of  psychology  
(n  =  4),  nursing  (n  =  2),  and  public  health  (n  =  4).  
Hypothesis  1  
Total  scale  level  content  validity  indices  (CVIs)  for  the  four  scales  ranged  from  .88  to  .92,  
based  upon  10  experts.  See  Table  1  for  scale  level  CVIs  in  addition  to  average  ratings  for  
clarity,  comprehensiveness,  and  appropriateness.  
   Three  items  were  developed  for  the  perceived  risk  scale  and  reviewed  by  the  10  content  
experts.  All  three  items  were  retained  since  they  were  all  rated  relevant  by  at  least  80%  (8  of  the  
10)  experts.  The  scale  level  CVI  for  the  perceived  risk  scale  was  .91.  Six  items  were  developed  
for  the  perceived  benefits  scale  and  reviewed  by  the  10  content  experts.  All  six  items  were  rated  
relevant  by  at  least  80%  of  the  experts  and  were  retained.  The  scale  level  CVI  for  the  perceived  
benefits  scale  was  .88.  
   Eighteen  items  were  initially  developed  for  the  perceived  barriers  scale  and  reviewed  by  
the  10  content  experts.  All  18  items  were  rated  relevant  by  80%  of  the  experts.  One  item  was  
deleted  from  the  original  scale,  resulting  in  the  final  17-­item  Likert-­style  scale.  Although  the  item  
“You  might  put  off  having  a  lung  scan  because  you  fear  feeling  stigmatized”  had  an  item  CVI  of  
.83,  the  item  was  deleted  because  the  concept  of  stigma  was  captured  more  clearly  in  two  other  
scale  items:  1)  “You  might  put  off  having  a  lung  scan  because  you  worry  about  feeling  like  a  
social  outcast”  and  2)  “You  might  put  off  having  a  lung  scan  because  you  worry  about  being  
blamed  for  having  smoked.”  In  addition,  the  authors  were  concerned  that  some  participants  
might  not  understand  the  meaning  of  “stigmatized.”  The  scale  level  CVI  for  the  perceived  
barriers  scale  was  .92.  
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   Nine  items  were  developed  for  the  self-­efficacy  scale  and  reviewed  by  the  content  
experts,  and  all  were  rated  relevant  by  80%  of  the  experts.  However,  two  items  were  revised  
from  the  original  scale  to  better  capture  what  the  individual  may  or  may  not  be  confident  about:  
(1)  “How  confident  are  you  that  you  can  have  a  lung  scan  even  if  you  don’t  know  what  to  
expect?”  was  revised  to  “How  confident  are  you  that  you  can  have  a  lung  scan  even  if  you  don’t  
know  what  to  expect  about  the  procedure?”  and  (2)  “How  confident  are  you  that  you  can  have  a  
lung  scan  even  if  you  are  anxious?”  was  revised  to  “How  confident  are  you  that  you  can  have  a  
lung  scan  even  if  you  are  anxious  about  the  process?”  The  scale  level  CVI  for  the  self-­efficacy  
scale  was  .91.  See  Table  2  for  the  items  comprising  the  final  scales  and  their  associated  item-­
level  CVIs.  
Phase  II:  Reliability  and  Construct  Validity  
Participants  (N  =  497)  who  were  eligible  for  lung  cancer  screening  were  fairly  evenly  
distributed  by  gender  and  smoking  status.  Ages  ranged  from  55  to  77  years  (M  =  62.8,  SD  =  
5.8),  and  77.8%  of  the  participants  were  non-­Hispanic  Caucasian.  Participants  were  fairly  well  
educated,  with  68.5%  having  some  college  or  higher.  See  Table  3  for  participant  
sociodemographic  characteristics.  
Hypothesis  2  
Internal  consistency  was  estimated  using  Cronbach’s  alpha  and  found  to  be  .88  for  the  
3-­item  perceived  risk  scale,  .80  for  the  6-­item  perceived  benefits  scale,  .89  for  the  17-­item  
perceived  barriers  scale,  and  .92  for  the  9-­item  self-­efficacy  scale,  exceeding  the  established  
acceptable  criteria  of  .70  for  internal  consistency  reliability.  
Hypothesis  3  
   There  were  no  significant  differences  between  screeners  and  non-­screeners  for  total  
perceived  risk  scores  (6.55  vs.  6.51;;  p=.84).  However,  significant  differences  were  observed  
between  groups  for  total  perceived  benefits,  total  self-­efficacy,  and  total  perceived  barriers  
scores  in  the  hypothesized  theoretical  directions.  Screeners  had  significantly  higher  total  
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perceived  benefits  (18.07  vs.  16.68;;  p=.0016)  and  self-­efficacy  scores  (30.38  vs.  28.55;;  
p=.0012)  and  lower  total  perceived  barriers  (33.05  vs.  35.03;;  p=.0387)  scores  (see  Table  4).  
Hypothesis  4  
A  4-­factor  confirmatory  factor  analysis  (CFA)  representing  the  theoretical  model  
(perceived  risk,  perceived  benefits,  perceived  barriers,  and  self-­efficacy)  was  performed.  Fit  
statistics  showed  the  data  fitting  the  4-­factor  model  well  with  a  Standardized  Root  Mean  Square  
Residual  (SRMR)  value  of  .074.  SRMR  is  the  standardized  difference  between  the  observed  
correlation  and  the  predicted  correlation;;  a  value  of  <  .08  is  considered  good  fit.21  The  CFA  had  
a  Root  Mean  Square  Error  of  Approximation  (RMSEA)  of  .087  showing  moderate  fit.  The  
RMSEA  is  related  to  the  residual  of  the  model,  with  values  ranging  from  0  to  1,  with  smaller  
numbers  indicating  a  better  fit.  An  RMSEA  of  .06  or  less  is  considered  good  fit.21  However,  inter-­
factor  correlations  were  all  low  (<  .20),  giving  further  strength  to  the  hypothesis  that  the  four  
factors  (i.e.,  scales)  are  distinct.  Model  modification  indices  suggestions  were  followed,  but  
model  fit  did  not  improve  when  the  few  paths  with  a  high  index  were  excluded;;  scale  items  were  
only  excluded  and  not  switched  between  factors.  As  additional  confirmatory  evidence,  each  of  
the  scales  was  also  fit  well  by  a  separate  single-­factor  CFA  model.    
Discussion  
   This  paper  details  the  development  and  psychometric  testing  of  the  Lung  Cancer  
Screening  Health  Belief  Scales.  Expanded  HBM  constructs  have  predicted  participation  in  other  
types  of  cancer  screening  (e.g.,  breast  and  colorectal  cancer  screening),  and  valid  and  reliable  
measures  of  HBM  constructs  in  breast  and  colorectal  cancer  screening  have  subsequently  
informed  tailored  interventions  that  increased  screening  uptake  in  those  cancers.  Lung  cancer  
screening  is  a  recent  recommendation.  However,  for  lung  cancer  screening  to  be  effective,  
individual  decision-­making  and  participation  are  necessary.  Therefore,  we  must  understand  
factors  that  may  influence  screening  including  the  individuals’  perspectives  and  their  beliefs  
about  lung  cancer  screening.  Theoretically-­based  scales  are  needed  and  the  psychometric  
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testing  of  the  Lung  Cancer  Screening  Health  Belief  Scales  provides  evidence  that  HBM  
constructs  can  be  validly  and  reliably  measured  in  the  context  of  lung  cancer  screening  
participation.  
Previous  research  has  shown  that  health  beliefs  about  cancer  and  cancer  screening  are  
important  predictors  of  screening  behavior.  The  results  of  this  psychometric  study  support  
previous  findings  that  perceived  benefits,  perceived  barriers,  and  self-­efficacy  are  associated  
with  screening  behavior  in  the  same  theoretically  proposed  directions  in  lung  cancer  as  in  
colorectal  and  breast  cancer.  To  our  knowledge  health  beliefs  have  not  been  examined  in  the  
context  of  actual  screening  behavior,  but  have  been  examined  in  the  context  of  intention  to  
screen  for  lung  cancer.  Jonnalagadda  et  al.  reported  that  increased  self-­efficacy  was  associated  
with  intention  to  screen  whereas  specific  barriers  such  as  concerns  about  radiation  effects  and  
discomfort  of  the  screening  procedure  were  associated  with  decreased  intention  to  screen.22  
Although  some  studies  have  shown  perceived  risk  to  be  predictive  of  cancer  screening  
behavior,23-­25  other  studies  have  shown  no  association  between  the  two  variables.26-­28  
Individuals  eligible  for  lung  cancer  screening  are  long-­term  smokers,  and  smokers  are  a  unique  
population  different  from  those  targeted  for  other  types  of  cancer  screening.  Smokers  
experience  stigma,  battle  an  addiction  to  nicotine,  and  perceive  blame  from  others  related  to  the  
perceived  self-­infliction  of  tobacco-­related  diseases  secondary  to  lifestyle  choices.  It  is  possible  
that  other  important  variables  such  as  perceived  stigma,  medical  mistrust,  cancer  fatalism,  fear  
and  worry  may  be  uniquely  relevant  in  lung  cancer  screening  and  may  mediate  the  relationship  
between  perceived  risk  and  lung  cancer  screening  participation.  
Development  of  the  Lung  Cancer  Screening  Health  Belief  Scales  adds  to  the  current  
state  of  the  science  by  providing  psychometrically  valid  and  reliable,  theoretically  grounded  
measures  of  individual  health  beliefs  in  lung  cancer  screening.  These  scales  can  be  used  in  
future  research  to  assess  these  individual  level  factors  that  may  influence  lung  cancer  screening  
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participation  and  provide  a  means  of  identifying  potentially  modifiable  targets  on  which  to  
intervene.  
Limitations  
   Although  the  Lung  Cancer  Screening  Health  Belief  Scales  show  promising  results,  
several  limitations  must  be  acknowledged.  First,  though  multiple  recruitment  methods  were  
employed,  more  than  50%  of  the  surveys  were  collected  online  which  may  have  introduced  the  
bias  of  lack  of  sample  diversity.  Specifically,  beliefs  related  to  lung  cancer  screening  may  be  
different  for  those  recruited  online  compared  to  the  general  population  of  long-­term  smokers.  In  
addition,  the  study  is  limited  by  the  availability  of  individuals  who  have  completed  lung  cancer  
screening,  likely  related  to  the  recent  official  recommendation  of  lung  cancer  screening  by  
organizations  such  as  the  American  Cancer  Society  and  U.S.  Preventive  Services  Task  Force.  
As  lung  cancer  screening  becomes  more  widely  implemented,  it  will  be  important  to  continue  to  
test  relationships  between  these  Expanded  HBM  constructs  and  lung  cancer  screening  behavior  
as  the  numbers  of  people  who  have  been  screened  for  lung  cancer  grow.    
Conclusions  
   The  present  study  provides  an  initial  assessment  of  the  reliability  and  validity  of  four  new  
scales  developed  to  measure  HBM  constructs  in  the  context  of  lung  cancer  screening.  This  
paper  expands  the  limited  body  of  knowledge  on  individual  health  beliefs  specific  to  lung  cancer  
screening  by  not  only  psychometrically  testing  the  HBM  constructs  in  the  context  of  lung  cancer  
screening,  but  also  providing  support  that  individuals  who  have  an  increased  level  of  perceived  
benefit  and  self-­efficacy  and  decreased  perceived  barriers  to  lung  cancer  screening  are  more  
likely  to  screen  for  lung  cancer.  Future  research  is  needed  on  all  HBM  constructs  in  the  context  
of  lung  cancer  screening  including  examination  of  other  key  variables  that  may  be  important.  
Specifically,  research  examining  the  potential  mediation  effect  of  variables  such  as  perceived  
stigma,  medical  mistrust,  cancer  fatalism,  fear  and  worry  on  health  beliefs  about  lung  cancer  
screening  is  critical.  Identification  of  long-­term  current  and  former  smokers  who  are  more  likely  
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to  screen  for  lung  cancer  will  be  useful  for  investigators  interested  in  developing  and  testing  
interventions  addressing  health  beliefs  regarding  lung  cancer  screening.  Ultimately,  
interventions  tailored  to  the  individual  at  risk  for  the  development  of  lung  cancer  will  benefit  from  
designs  that  take  individual  health  beliefs  into  consideration.  
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Table  1.  Total  Scale  Level  Content  Validity  Indices  for  Lung  Cancer  Screening  Health  Belief  Scales  (based  upon  10  content  experts)  









Perceived	  Risk	  of	  Lung	  Cancer	  Scale	   .91	   .91	   .93	   .88	  
Perceived	  Benefits	  of	  Lung	  Cancer	  Screening	  Scale	   .88	   .87	   .95	   .92	  
Perceived	  Barriers	  to	  Lung	  Cancer	  Screening	  Scale	   .92	   .86	   .95	   .90	  
Self-­‐Efficacy	  for	  Lung	  Cancer	  Screening	  Scale	   .91	   .89	   .95	   .83	  











1.  It  is  likely  that  I  will  get  lung  cancer  sometime  in  my  lifetime.   .98  
2.  It  is  likely  that  I  will  get  lung  cancer  in  the  next  ten  years.   .88  
3.  It  is  likely  that  I  will  get  lung  cancer  in  the  next  five  years.   .83  
     
Perceived  Benefits  of  Lung  Cancer  Screening  Scale  (LCSHB-­PBen)     
1.  Having  a  lung  scan  will  help  find  lung  cancer  early.   .95  
2.  Having  a  lung  scan  will  lower  my  chances  of  dying  from  lung  cancer.   .93  
3.  Having  a  lung  scan  will  help  me  not  worry  as  much  about  lung  cancer   .93  
4.  Having  a  lung  scan  will  help  me  plan  for  the  future.   .83  
5.  Having  a  lung  scan  will  help  my  family  not  worry  as  much.   .85  
6.  Having  a  lung  scan  will  give  me  peace  of  mind.   .93  
     
Perceived  Barriers  to  Lung  Cancer  Screening  Scale  (LCSHB-­PBarr)     
1.  I  might  put  off  having  a  lung  scan  because  I  worry  about  finding  something  wrong.   .98  
2.  I  might  put  off  having  a  lung  scan  because  I  don’t  have  the  time.   .98  
3.  I  might  put  off  having  a  lung  scan  because  I  don’t  have  a  regular  healthcare  provider.   1.00  
4.  I  might  put  off  having  a  lung  scan  because  no  one  in  my  family  had  lung  cancer.   .83  
5.  I  might  put  off  having  a  lung  scan  because  the  cost  would  be  a  problem.   .98  
6.  I  might  put  off  having  a  lung  scan  because  I  don’t  have  any  lung  problems  or  symptoms.   1.00  
7.  I  might  put  off  having  a  lung  scan  because  transportation  would  be  a  problem.   .95  
8.  I  might  put  off  having  a  lung  scan  because  I  am  afraid  the  lung  scan  will  damage  my  
lungs.   .95  
9.  I  might  put  off  having  a  lung  scan  because  I  have  had  a  bad  experience  with  a  hospital  or  
healthcare  provider.   .88  
10.  I  might  put  off  having  a  lung  scan  because  I  don’t  know  enough  about  the  test.   1.00  
11.  I  might  put  off  having  a  lung  scan  because  I  think  I  am  too  old  to  benefit  from  screening  
for  lung  cancer.   .93  
12.  I  might  put  off  having  a  lung  scan  because  I  am  a  smoker.   .70  
13.  I  might  put  off  having  a  lung  scan  because  I  would  rather  not  know  if  I  have  any  lung  
problems.   .98  
14.  I  might  put  off  having  a  lung  scan  because  I  worry  about  feeling  like  a  social  outcast  for  
smoking.   .88  
15.  I  might  put  off  having  a  lung  scan  because  I  worry  about  being  blamed  for  having  
smoked.   .98  
16.  I  might  put  off  having  a  lung  scan  because  it  is  not  worth  the  effort.   .93  
17.  I  might  put  off  having  a  lung  scan  because  I  do  not  trust  the  healthcare  system.   .83  
     
Self-­Efficacy  for  Lung  Cancer  Screening  Scale  (LCSHB-­SE)     
1.  How  confident  are  you  that  you  can  make  an  appointment  to  have  a  lung  scan?   .93  
2.  How  confident  are  you  that  you  can  find  the  time  to  have  a  lung  scan?   1.00  
3.  How  confident  are  you  that  you  can  find  transportation  to  get  to  and  from  the  clinic/hospital  
to  have  a  lung  scan?   1.00  
4.  How  confident  are  you  that  you  can  get  enough  information  about  having  a  lung  scan?   .98  
5.  How  confident  are  you  that  you  can  cover  the  cost  of  a  lung  scan,  if  needed?   .83  
6.  How  confident  are  you  that  you  can  get  a  lung  scan  even  if  you  are  worried  about  the  
results?   .95  
  7.  How  confident  are  you  that  you  can  have  a  lung  scan  even  if  you  don’t  know  what  to  
expect  about  the  procedure?   .90  
8.  How  confident  are  you  that  you  can  even  if  you  are  anxious  about  the  process?   .80  
9.  How  confident  are  you  that  you  can  even  if  you  are  anxious  about  the  results?   .85  
Table	  3.	  Participant	  Sociodemographic	  Characteristics	  
	   Overall	  (n=497)	  
	  𝑋	  (SD)	  
Median	  (Range)	  
Screened/Intend	  
to	  Screen	  (n=146)	  𝑋	  (SD)	  
Median	  (Range)	  
Unscreened	  






Age	   62.76	  (5.80);	  
62	  (55-­‐77)	  
62.66	  (5.15);	  	  	  
62.5	  	  	  (55-­‐77)	  
62.81	  (6.06);	  	  	  	  	  
62	  (55-­‐76)	  
.8050	  
Pack	  Years	   50.49	  (23.61);	  	  
44	  (1-­‐150)	  
52.07	  (27.08);	  
43.5	  	  	  (	  	  9-­‐150)	  
49.83	  (21.99);	  	  	  	  
44	  (1	  –	  148)	  
.3781	  
Total	  Perceived	  Smoking-­‐related	  
Stigma	  
14.10	  (3.28);	  	  
15	  	  	  	  	  	  (0-­‐20)	  
13.31	  (4.15);	  
14	  	  	  	  	  	  (0-­‐18)	  
14.32	  (2.98);	  	  
15	  	  	  	  	  	  (6-­‐20)	  
.2276	  
	   n	  (%)	   	   	   	  
Education	   	   	   	   	  
	  	  	  	  Less	  than	  High	  School	   20	  (4.0)	   3	  (2.1)	   17	  (4.8)	   .0061*	  
	  	  	  	  High	  School	  Graduate	   136	  (27.4)	   34	  (23.5)	   102	  (29.1)	   	  
	  	  	  	  Some	  College	   208	  (41.9)	   54	  (37.2)	   154	  (43.9)	   	  
	  	  	  	  College	  Graduate	  or	  Higher	   132	  (26.6)	   54	  (37.2)	   78	  (22.2)	   	  
Race	   	   	   	   	  
	  	  	  Caucasian	   385	  (77.8)	   112	  (76.7)	   273	  (78.2)	   .6328	  
	  	  	  African-­‐American	   103	  (20.8)	   31	  (21.2)	   72	  (20.6)	   	  
	  	  	  Asian	   1	  (0.2)	   1	  (0.7)	   0	   	  
	  	  	  American-­‐Indian	   3	  (0.6)	   1	  (0.7)	   2	  (0.6)	   	  
	  	  	  Other	  Pacific	  Islander	   2	  (0.4)	   1	  (0.7)	   1	  (0.3)	   	  
	  	  	  Multiracial	   1	  (0.2)	   0	   1	  (0.3)	   	  
Hispanic	   24	  (4.8)	   4	  (2.7)	   20	  (5.7)	   .2491	  
Gender	  (Male)	   191	  (38.5)	   64	  (43.8)	   127	  (36.3)	   .2147	  
Income	   	   	   	   	  
	  	  	  Less	  than	  $25,000	  per	  year	   156	  (31.6)	   36	  (24.8)	   120	  (34.5)	   .0185*	  
	  	  	  $25,000	  to	  $50,000	  per	  year	   227	  (46.0)	   66	  (45.5)	   161	  (46.3)	   	  
	  	  	  Greater	  than	  $50,000	  per	  year	   110	  (22.3)	   43	  (29.7)	   67	  (19.3)	   	  
Insurance	   	   	   	   	  
	  	  	  Government	  Sponsored	   284	  (57.3)	   81	  (55.9)	   203	  (57.8)	   .9223	  
	  	  	  Private	  Health	  Insurance	   192	  (38.7)	   58	  (40.0)	   134	  (38.2)	   	  
	  	  	  Uninsured	   20	  (4.0)	   6	  (4.1)	   14	  (4.0)	   	  
Smoking	  Status	  (yes)	   239	  (48.6)	   67	  (46.5)	   172	  (49.4)	   .6203	  
Values	  are	  mean	  (standard	  deviation);	  median	  (minimum-­‐maximum)	  for	  continuous	  variables	  and	  frequency	  
(percent)	  for	  categorical	  variables.	  	  	  P-­‐values	  are	  from	  Student’s	  t-­‐test	  for	  continuous	  variables	  and	  Fisher’s	  
Exact	  Test	  for	  categorical	  variables.	  
	  
Table	  4.	  Scale	  Means	  Examining	  Differences	  Between	  Participants	  Who	  Intend	  to	  and	  Have	  Screened	  for	  Lung	  Cancer	  and	  Unscreened	  Participants	  
	   	  
Scale	  Range	  
Overall	  (n=496)	  𝑋	  (SD);	  Median	  (Range)	   Screened/Intend	  to	  Screen	  (n=146)	  𝑋	  (SD);	  Median	  (Range)	   Nonscreened	  (n=350)	  𝑋	  (SD);	  Median	  (Range)	   	  p-­‐value	  
Total	  Perceived	  Risk	   3-­‐12	   6.52	  (2.26);	  6	  (2-­‐12)	   6.55	  (2.47);	  6	  (2-­‐12)	   6.51	  (2.17);	  6	  (2-­‐12)	   	  	  	  	  .8428	  
Total	  Perceived	  Benefits	   6-­‐24	   17.09	  (4.48);	  18	  (2-­‐24)	   18.07	  (4.14);	  18	  (3-­‐24)	   16.68	  (4.55);	  18	  (2-­‐24)	   .0016*	  
Total	  Perceived	  Barriers	   17-­‐68	   34.44	  (9.08);	  35	  (7-­‐65)	   33.05	  (10.07);	  34	  (14-­‐65)	   35.03	  (8.58);	  36	  (7-­‐55)	   .0387*	  
Total	  Self-­‐Efficacy	   9-­‐36	   29.10	  (6.25);	  30	  (1-­‐36)	   30.38	  (5.29);	  32	  (8-­‐36)	   28.55	  (6.55);	  29	  (1-­‐36)	   .0012*	  
Values	  are	  mean	  (standard	  deviation);	  median	  (range);	  p-­‐values	  are	  from	  Wilcoxon	  non-­‐parametric	  test.	  
(There	  are	  five	  participants	  without	  “stage”	  data	  so	  they	  have	  been	  excluded	  from	  all	  analyses.)	  
	  
	  
